EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

The oncogenic driving force of CD30 signaling‐induced chromosomal instability in adult T‐cell leukemia/lymphoma

Makoto Nakashima iD, Atae Utsunomiya iD, Toshiki Watanabe, Ryouichi Horie iD, Kaoru Uchimaru

Cancer Science · 2023

DOI: 10.1111/cas.15706 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Science, 2023. Verfasst von Makoto Nakashima und 4 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Tumor Cell Biology, Department of Computational Biology and Medical Sciences, Graduate School of Frontier Sciences, University of Tokyo…. Hauptthemen laut MEDLINE: Leukemia-Lymphoma, Adult T-Cell, Human T-lymphotropic virus 1, Lymphoma. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Japan Agency for Medical Research and Development, Japan Society for the Promotion of Science, Takeda Pharmaceutical Company.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Adult T‐cell leukemia/lymphoma (ATL) develops via stepwise accumulation of gene mutations and chromosome aberrations. However, the molecular mechanisms underlying this tumorigenic process are poorly understood. We previously reported the presence of a biological link between the expression of CD30, which serves as a marker for ATL progression, and the actively proliferating fraction of human T‐cell leukemia virus type 1 (HTLV‐1)‐infected cells that display polylobulation. Here, we demonstrated that CD30 signaling induced chromosomal instability with clonal expansion through DNA double‐strand breaks (DSBs) via an increase of intracellular reactive oxygen species. CD30 + ATL cells were composed of subclones with additional genomic aberrations compared with CD30 − ATL cells in ATL patients. Furthermore, we found an accumulation of copy number loss of DSB repair‐related genes as the disease progressed. Taken together, CD30 expression on ATL cells appears to be correlated with genomic instability, suggesting that CD30 signaling is one of the oncogenic factors of ATL progression with clonal evolution. This study provides new insight into the biological roles of CD30 signaling and could improve our understanding of tumorigenic processes of HTLV‐1‐infected cells.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Leukemia-Lymphoma, Adult T-CellHuman T-lymphotropic virus 1LymphomaAdultHumansSignal TransductionChromosomal Instability

Stichwörter der Autor:innen

CD30 signalingDNA double-strand breakschromosomal instabilitylymphomagenesisreactive oxygen species

Autor:innen und Institutionen

  • Laboratory of Tumor Cell Biology, Department of Computational Biology and Medical Sciences, Graduate School of Frontier Sciences, University of Tokyo, Tokyo, Japan.
  • Department of Hematology, Imamura General Hospital, Kagoshima, Japan.
  • Laboratory of Practical Management of Medical Information, Graduate School of Medicine, St. Marianna University, Kawasaki, Kanagawa, Japan.
  • Division of Hematology, Department of Laboratory Sciences, School of Allied Health Sciences, Kitasato University, Sagamihara, Kanagawa, Japan.

ORCID-Profile: Makoto Nakashima, Atae Utsunomiya, Ryouichi Horie

Förderung

  • Japan Agency for Medical Research and Development
  • Japan Society for the Promotion of Science
  • Takeda Pharmaceutical Company

Zitieren

APA

Nakashima, M., Utsunomiya, A., Watanabe, T., Horie, R., & Uchimaru, K. (2023). The oncogenic driving force of CD30 signaling‐induced chromosomal instability in adult T‐cell leukemia/lymphoma. Cancer Science. https://doi.org/10.1111/cas.15706

Vancouver

Nakashima M, Utsunomiya A, Watanabe T, Horie R, Uchimaru K. The oncogenic driving force of CD30 signaling‐induced chromosomal instability in adult T‐cell leukemia/lymphoma. Cancer Science. 2023. doi:10.1111/cas.15706

BibTeX
@article{Nakashima2023,
  author = {Nakashima, Makoto and Utsunomiya, Atae and Watanabe, Toshiki and Horie, Ryouichi and Uchimaru, Kaoru},
  title = {The oncogenic driving force of CD30 signaling‐induced chromosomal instability in adult T‐cell leukemia/lymphoma},
  journal = {Cancer Science},
  year = {2023},
  doi = {10.1111/cas.15706}
}
Kostenlos starten →